Context Therapeutics

3d rendering of a semi-opened steel safe box with many paper dollar banknotes flying out of it
Biotech

Context builds bispecific bank with $133M biobucks deal

For further context, the antibody binds to Nectin-4 on tumor cells and CD3 on T cells, galvanizing the T cells to attack the cancer.
Darren Incorvaia Sep 23, 2024 11:20am
Stop sign

Assembly, Context and Innate add to pile of dumped R&D prospects

Mar 23, 2023 8:00am
boxing gloves

Context cuts excess fat to carry biotech into ‘24

Sep 28, 2022 11:00am